Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2001, p. 1905-1907, Vol. 45, No. 6
Servicio de Micología, Centro
Nacional de Microbiología, Instituto de Salud Carlos III,
28220 Majadahonda (Madrid), Spain
Received 19 January 2001/Returned for modification 22 February
2001/Accepted 12 March 2001
The in vitro activity of the azasordarin GW 471558 was compared
with those of amphotericin B, flucytosine, itraconazole, and ketoconazole against 177 clinical isolates of Candida
spp. GW 471558 showed potent activity against Candida
albicans, Candida glabrata, and Candida
tropicalis, even against isolates with decreased susceptibility
to azoles. Candida krusei, Candida parapsilosis, Candida
lusitaniae, and Candida guilliermondii are
resistant to GW 471558 in vitro (MICs, >128 µg/ml).
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.6.1905-1907.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Azasordarins: Susceptibility of
Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of
Candida spp. to GW 471558
*
Corresponding author. Mailing address: Servicio de
Micología, Centro Nacional de Microbiología, Instituto
de Salud Carlos III, Ctra. Majadahonda-Pozuelo Km 2., 28220 Majadahonda
(Madrid), Spain. Phone: 34-91-5097961. Fax: 34-91-5097966. E-mail:
mcuenca-estrella{at}isciii.es.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»